Vibrating vest could help cough up mucus easier
NCT ID NCT07347366
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a special vest that vibrates to help loosen mucus in the lungs for people who have trouble coughing it up. About 45 hospitalized adults will use the vest and report how their breathing, cough, and mucus symptoms change. The goal is to see if this device is safe and effective for clearing lung secretions.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- High-frequency chest wall oscillation vest (CAREWAY device)
- What this could lead to
- If it works, this could offer a non-drug way to help people with lung congestion breathe easier and clear mucus more effectively.
- What could go wrong
- This is a small, early exploratory study with only 45 participants, so results may not apply to everyone. The device may not work better than standard care or could cause discomfort.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 45 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Sep 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Hospitalized patients who require sputum clearance. * Patients who present with fever or respiratory symptoms (cough, sputum) and, after confirmation of findings on imaging studies, are judged by the clinician to require sputum clearance. * Adult patients (≥ 18 years) who have signed the informed consent form, or patients for whom consent has been obtained from a legally authorized representative Exclusion Criteria: * Patients with severe pneumonia requiring intensive care unit (ICU) treatment. * Patients with major pulmonary diseases other than pneumonia, such as active tuberculosis or lung cancer. * Patients with severe respiratory failure (PaO₂/FiO₂ ≤ 200 mmHg). * Patients with hemodynamically unstable cardiovascular disease (myocardial infarction within the past 3 months, or heart failure of NYHA class 3 or higher). * Patients hospitalized for head and neck trauma whose surgical site has not yet healed. * Patients with serious cardiac arrhythmias or hemodynamic instability. * Patients who have had pneumothorax or massive hemoptysis within the past 6 months, or who currently have hemoptysis. * Patients who have undergone spinal surgery within the past 6 months or who have acute spinal injury. * Patients with osteoporosis. * Patients with bronchopleural fistula. * Pregnant or breastfeeding women. * Patients diagnosed with cervical disc disease. * Individuals who have participated in clinical studies two or more times in the same year, or who have participated in another clinical study within the past 6 months (however, patients enrolled in chronic lung disease cohort studies such as asthma or COPD are allowed). * Individuals who, in the judgment of the principal investigator or sub-investigator, have clinically significant findings that make them unsuitable for participation in this study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pneumonia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Rehab lab, Pusan National University Yangsan Hospital
RECRUITINGYangsan, Gyeongsangnam-do, 50612, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
- Nasal swab could curb unnecessary antibiotics in pneumonia
- AI could outsmart bacteria: a smarter way to choose antibiotics?
- Breathing technique may outperform spirometry for smog pneumonia recovery
- A gentle touch against coughs and colds: could manual therapy shorten respiratory illness?
- Can a smart oxygen device shorten hospital stays for pneumonia?